Patent Assignment
Reel/Frame 056135/0800
Intellectual Property Security Agreement
Recorded: 2021-05-04
Pages: 16
Assignor
XERIS PHARMACEUTICALS, INC.
Executed: 2021-05-03
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
115 SOUTH UNION STREET, SUITE 300, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(9)
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
PCT:
PCT/US2020/035172 ↗
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Application:
16/600,722 →
Publication:
US 2020/0215162
Methods for Treating Congenital Hyperinsulinism
Application:
16/630,774 →
Publication:
US 2020/0147306
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
Application:
16/955,698 →
Publication:
US 2021/0008170
Treatment of Post-Bariatric Hypoglycemia Using Mini-Dose Stable Glucagon
Application:
16/964,124 →
Publication:
US 2021/0030847
Stable Formulations for Parenteral Injection of Peptide Drugs
Application:
17/215,449 →
Publication:
US 2021/0315961
Stable Sustained Release Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Application:
63/044,973 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 31, 2020
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 052276/0012 →
Assignment of Assignor's Interest
Aug 12, 2020
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 053480/0851 →
Assignment of Assignor's Interest
Sep 29, 2020
From: CASSAVAUGH, EVAN; PRESTRELSKI, STEVEN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 053915/0648 →
Assignment of Assignor's Interest
Nov 2, 2020
From: PATTI, MARY-ELIZABETH
To: JOSLIN DIABETES CENTER, INC.
Reel/Frame 054245/0816 →
Assignment of Assignor's Interest
Nov 2, 2020
From: NEWSWANGER, BRETT; PRESTRELSKI, STEVEN J.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 054245/0626 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →
Assignment of Assignor's Interest
Nov 10, 2022
From: DONOVAN, MARTIN; HU, WENDY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 061721/0694 →
Security Interest
Mar 5, 2024
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LTD.
To: HAYFIN SERVICES LLP
Reel/Frame 066647/0595 →
Assignment of Assignor's Interest
Aug 19, 2025
From: PRESTRELSKI, STEVEN J.; KINZELL, JOHN; NEWSWANGER, BRETT; THORNTON, PAUL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072061/0127 →
Change of Address
Aug 29, 2025
From: XERIS PHARMACEUTICALS, INC.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072771/0247 →
Assignment of Assignor's Interest
Nov 24, 2025
From: PRESTRELSKI, STEVEN; NEWSWANGER, BRETT; CUMMINS, MARTIN; RIDDELL, MICHAEL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 073022/0053 →